Heterocyclic Anticancer Agents

Bimal Krishna Banik, Bubun Banerjee

Producción científica: Informe/libroLibrorevisión exhaustiva

6 Citas (Scopus)

Resumen

Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles. Explores heterocycles and their use as anticancer therapies. Contains chapters on various heterocyclic derrivatives, the impact of heterocycles on anticancer agent development, and naturally occuring heterocycles.

Idioma originalInglés
Editorialde Gruyter
Número de páginas512
ISBN (versión digital)9783110735772
ISBN (versión impresa)9783110739268
DOI
EstadoPublicada - 21 jun. 2022
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Heterocyclic Anticancer Agents'. En conjunto forman una huella única.

Citar esto